Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial
- Norman, JE
- Marlow, N
- Messow, C-M
- Shennan, A
- Bennett, PR
- Thornton, S
- Robson, SC
- McConnachie, A
- Petrou, S
- Sebire, NJ
- Lavender, T
- Whyte, S
- Norrie, J
- Grp, OPPTIMUMS
DOIAbstract
Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC) and National Institute for Health Research (NIHR) partnership. The EME Programme is funded by the MRC and NIHR, with contributions from the Chief Scientist Office in Scotland and National Institute for Social Care and Research in Wales
Add to ORKG